MariMed第四季度调整后每股亏损$(0.01),符合预期,销售额$39.00M低于$41.95M预期

财报速递2025-03-06
MariMed (OTC:MRMD) 报告季度每股亏损$(0.01),符合分析师的一致预期。这比去年同期的$0.00每股收益减少了300%。该公司报告季度销售额为$39.00百万,低于分析师一致预期的$41.95百万,差距为7.03%。这比去年同期的$38.90百万销售额增加了0.26%。

以上内容来自Benzinga Earnings专栏,原文如下:

MariMed (OTC:MRMD) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 300 percent decrease over earnings of $0.00 per share from the same period last year. The company reported quarterly sales of $39.00 million which missed the analyst consensus estimate of $41.95 million by 7.03 percent. This is a 0.26 percent increase over sales of $38.90 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法